USE OF TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL TRPV3 IN DEVELOPING DRUG FOR PREVENTION OR TREATMENT OF PSORIASIS

Title:

USE OF TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL TRPV3 IN DEVELOPING DRUG FOR PREVENTION OR TREATMENT OF PSORIASIS

Document Type and Number:

WIPO Patent Application WO/2019/192239

Kind Code:

A1

Abstract:

Disclosed is a pathophysiological effect of the transient receptor potential cation channel, subfamily V, member 3 (TRPV3) on psoriasis, wherein TRPV3 can be used as a target in developing a drug for the treatment of psoriasis.

More Like This:

WO/2001/017522	METHOD OF TREATING CANCER USING TETRAETHYL THIURAM DISULFIDE
WO/2023/167033	PRORENIN RECEPTOR PEPTIDE, CONJUGATE, AND PHARMACEUTICAL COMPOSITION
WO/2004/054618	DRUGS FOR INHIBITING REJECTION REACTION IN TISSUE TRANSPLANTED INTO MAMMALIAN TISSUE AND METHOD OF TREATING DIABETES USING THE SAME

Inventors:

CAO ZHENGYU (CN)
WANG YUJING (CN)

Application Number:

PCT/CN2019/070763

Publication Date:

October 10, 2019

Filing Date:

January 08, 2019

Export Citation:

Click for automatic bibliography generation Help

Assignee:

UNIV CHINA PHARMA (CN)

International Classes:

A61K45/00; A61P17/06

Domestic Patent References:

WO2008033564A1	2008-03-20
WO2014040178A1	2014-03-20

Foreign References:

CN101233132A	2008-07-30
CN101355946A	2009-01-28
US20100137260A1	2010-06-03

Attorney, Agent or Firm:

NANJING SUGAO PATENT AND TRADEMARK FIRM (ORDINARY PARTNERSHIP) (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: DIFFRACTIVE OPTICAL COMPONENT, LASER PROJECTION MODULE, DEPTH CAMERA, AND ELECTRONIC DEVICE

Next Patent: LASER EMITTER, OPTOELECTRONIC APPARATUS, DEPTH CAMERA AND ELECTRONIC DEVICE